AND-Logic-Based Dual-Lock Hemicyanine Fluorescence Probe for Accurate Hypoxia Assessment in Tumors
The hypoxia tumor microenvironment (TME) critically influences treatment efficacy, driving a significant demand for real-time in vivo hypoxia assessment. However, conventional single-stimulus responsive probes suffer from insufficient imaging precision. To address this, we developed a new AND-logic-based pH/nitroreductase (NTR) dual-lock hemicyanine, namely LET-16, for accurate hypoxia assessment in tumors. LET-16 responds to acidic TME, forming a positively charged open-ring structure that enhances cell entry. Inside tumor cells, it reacts with overexpressed NTR, thus emitting a fluorescence signal. LET-16 demonstrates excellent dual-responsive activation both in vitro and in vivo, enabling precise imaging of tumor hypoxia. This work not only provides a robust tool for accurate hypoxia assessment but also offers a strategy for engineering versatile hemicyanine scaffolds adaptable to complex diagnostic needs, such as multianalyte detection and advanced logic-gate responses.
Authors
- Hengke Liu (ORCID: https://orcid.org/0000-0002-5624-339X)
- Yurong Liu (ORCID: https://orcid.org/0000-0002-2459-6617)
- Peng Fei Huang (ORCID: https://orcid.org/0000-0003-3651-7813)
- Xuan Zhou (ORCID: https://orcid.org/0000-0003-3919-0342)
- Jing Lin (ORCID: https://orcid.org/0000-0001-9865-2098)
- Junjie Chen (ORCID: https://orcid.org/0009-0005-2665-1279)
- Yue Li (ORCID: https://orcid.org/0000-0003-0994-8714)
- Yaru Wang (ORCID: https://orcid.org/0000-0002-4510-4335)
- Wei Sun (ORCID: https://orcid.org/0000-0001-5266-1933)
- Shanshan Jiang (ORCID: https://orcid.org/0009-0004-4409-320X)
Institutions
- Shenzhen Institute of Information Technology (CN)
- Shenzhen University (CN)
- TianjinSino-German University of Applied Sciences (CN)
- Theranostics (New Zealand) (NZ)
- Shenzhen Technology University (CN)
- Wuyi University (CN)
Publication Details
- Journal
- Chemical & Biomedical Imaging
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1021/cbmi.5c00145
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00